Cite
Masson S, Caironi P, Fanizza C, et al. Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Med. 2015;41(9):1736doi: 10.1007/s00134-015-3982-z.
Masson, S., Caironi, P., Fanizza, C., Thomae, R., Bernasconi, R., Noto, A., Oggioni, R., Pasetti, G. S., Romero, M., Tognoni, G., Latini, R., & Gattinoni, L. (2015). Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive care medicine, 41(9), 1736. https://doi.org/10.1007/s00134-015-3982-z
Masson, Serge, et al. "Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial." Intensive care medicine vol. 41,9 (2015): 1736. doi: https://doi.org/10.1007/s00134-015-3982-z
Masson S, Caironi P, Fanizza C, Thomae R, Bernasconi R, Noto A, Oggioni R, Pasetti GS, Romero M, Tognoni G, Latini R, Gattinoni L. Erratum to: Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Med. 2015 Sep;41(9):1736. doi: 10.1007/s00134-015-3982-z. PMID: 26183490.
Copy
Download .nbib